Updated:
National Human Genome Research Institute
NHGRI was established in 1989 as the National Center for Human Genome Research, becoming an institute in 1997.
National Human Genome Research Institute
NHGRI was established in 1989 as the National Center for Human Genome Research, becoming an institute in 1997. Eric Green, a physician-scientist who trained under Francis Collins, took the director role in 2009. The institute's wealth origin is federal appropriations through the NIH budget, not private capital. The institute allocates its budget primarily to extramural research grants, intramural research programs, and the development of genomic technologies. It funds large-scale sequencing centers, including the Broad Institute and the Wellcome Sanger Institute, and supports projects like the Encyclopedia of DNA Elements (ENCODE) and the Human Genome Reference Program. Its geographic footprint is global, with funded research in North America, Europe, and Asia. NHGRI employs a professional staff of roughly 400 across its Bethesda campus and additional NIH facilities. The institute operates the Intramural Research Program, which conducts investigator-initiated research in genomic medicine, computational biology, and molecular genetics. In fiscal year 2024, NHGRI's budget was approximately $650 million (per NIH public data, 2024). NHGRI's structural differentiator is its mandate as a government institute uniquely dedicated to genomics—a mission that separates it from private research entities. Its funding flows through the NIH peer-review system, prioritizing open-access data sharing over proprietary returns. The institute has no succession structure typical of family offices, instead operating under federal leadership transitions.
General information
Firm type
Government Research Institute
Year founded
1989
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Bethesda
Corporate office
Bethesda, MD, United States
Principals
Eric Green
Director
Sector focus
Frequently asked questions
Who runs investment decisions at NHGRI?
Investment decisions at NHGRI are made through the NIH peer-review system. The institute's director, Eric Green, sets strategic priorities, but grant funding is allocated by external scientific reviewers. Intramural research decisions flow through institute leadership, guided by the NIH scientific mission.
How does NHGRI source proprietary deal flow?
NHGRI does not engage in proprietary deal flow. It funds research through competitive grants and operates an intramural program. Its 'deal flow' is based on investigator-initiated proposals and institute-identified scientific priorities, not market opportunities.
Is NHGRI structured as a single family office or does it operate more like a venture firm?
NHGRI is a federal government research institute under the National Institutes of Health. It operates as a grant-making and research organization, with no resemblance to a family office or venture firm.
Does NHGRI participate in fund commitments or only direct deals?
NHGRI does not participate in fund commitments or direct deals. It provides grants and contracts to academic and research institutions for genomic science. It holds no private investment portfolio.
What investment stages does NHGRI typically target?
NHGRI does not target investment stages. Its funding spans basic research through clinical translation, but it does not invest in equity or debt instruments.
How is NHGRI related to other NIH institutes?
NHGRI is one of 27 institutes and centers at the National Institutes of Health. It collaborates with other institutes on cross-cutting genomic initiatives but operates with its own budget and strategic plan.
Where does the underlying wealth come from?
NHGRI's funding comes from the US federal budget, appropriated by Congress through the NIH. There is no private wealth origin.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: